Document
IPR2023-00724, No. 1113 Exhibit - Exhibit 1113 Skrivanek (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1113 Exhibit - Exhibit 1113 Skrivanek (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2546 Exhibit - EX2546 Petitioner’s Motion for Joinder Under 35 USC 315c and 37 CFR 4222 and 42122b, Sun Pharmaceutical Industries Ltd v Novo Nordisk AS, IPR2024 0...
Cite Document
IPR2023-00724, No. 2546 Exhibit - EX2546 Petitioner’s Motion for Joinder Under 35 USC 315c and 37 CFR 4222 and 42122b, Sun Pharmaceutical Industries Ltd v Novo Nordisk AS, IPR2024 00107, Pap2 Nov 2,
+ More Snippets
Document
IPR2023-00724, No. 2537 Exhibit - EX2537 Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 122 cv 03038 CFC D D
Cite Document
IPR2023-00724, No. 2537 Exhibit - EX2537 Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 122 cv 03038 CFC D D
+ More Snippets
Document
IPR2023-00724, No. 1140 Exhibit - Exhibit 1140 Goland Dep (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1140 Exhibit - Exhibit 1140 Goland Dep (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2058 Exhibit - EX2058 Declaration of Sayem Osman (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2058 Exhibit - EX2058 Declaration of Sayem Osman (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2056-2 Exhibit - EX2056 EX2056 Declaration of Patrick Sinko, PhD REDACTED (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2056-2 Exhibit - EX2056 EX2056 Declaration of Patrick Sinko, PhD REDACTED (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2081 Exhibit - EX2081 Dani Blum, What’s Next for Ozempic, New York Times, December 20, 2023 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2081 Exhibit - EX2081 Dani Blum, What’s Next for Ozempic, New York Times, December 20, 2023 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1025 Exhibit - Glaesner 2010 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1025 Exhibit - Glaesner 2010 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 2555-2 Exhibit - EX2555 REDACTED Transcript of July 19, 2024 Deposition of DeForest McDuff (P.T.A.B. Aug. 5, 2024)
Cite Document
IPR2023-00724, No. 2555-2 Exhibit - EX2555 REDACTED Transcript of July 19, 2024 Deposition of DeForest McDuff (P.T.A.B. Aug. 5, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2536 Exhibit - EX2536 Partial Transcript of July 22, 2024 Conference Call (P.T.A.B. Jul. 25, 2024)
Cite Document
IPR2023-00724, No. 2536 Exhibit - EX2536 Partial Transcript of July 22, 2024 Conference Call (P.T.A.B. Jul. 25, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1311 Exhibit - Exhibit 1311 Redacted Flint Dep (P.T.A.B. Jun. 21, 2024)
Cite Document
IPR2023-00724, No. 1311 Exhibit - Exhibit 1311 Redacted Flint Dep (P.T.A.B. Jun. 21, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2550 Exhibit - EX2550 Sun Pharmaceutical Industries Ltd’s and Sun Pharmaceutical In dustries Inc’s Stipulation of Invalidity Contentions, In re Ozempic Semaglutide Pate...
Cite Document
IPR2023-00724, No. 2550 Exhibit - EX2550 Sun Pharmaceutical Industries Ltd’s and Sun Pharmaceutical In dustries Inc’s Stipulation of Invalidity Contentions, In re Ozempic Semaglutide Patent Litigati
+ More Snippets
Document
IPR2023-00724, No. 2075 Exhibit - EX2075 Madsbad, S et al, “Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once Daily Treatment With the Long Ac...
Cite Document
IPR2023-00724, No. 2075 Exhibit - EX2075 Madsbad, S et al, “Improved Glycemic Control With No Weight Increase in Patients With Type 2 Diabetes After Once Daily Treatment With the Long Acting Glucago
+ More Snippets
Document
IPR2023-00724, No. 2452 Exhibit - EX2452 Synjardy Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2452 Exhibit - EX2452 Synjardy Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2385 Exhibit - EX2385 Wilding, JPH, The importance of weight management in type 2 diabetes mellitus, Int J Clin Pract, 2014 Jun 686682 691 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2385 Exhibit - EX2385 Wilding, JPH, The importance of weight management in type 2 diabetes mellitus, Int J Clin Pract, 2014 Jun 686682 691 (P.T.A.B. Jan. 17, 2024)
+ More Snippets